Trupanion (NASDAQ:TRUP) Price Target Increased to $45.00 by Analysts at Piper Sandler

Trupanion (NASDAQ:TRUP) had its target price boosted by equities researchers at Piper Sandler from $38.00 to $45.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. Piper Sandler’s price objective indicates a potential upside of 9.25% from the company’s previous close.

A number of other equities analysts have also weighed in on the stock. Bank of America lifted their price objective on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Northland Securities boosted their price target on shares of Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. William Blair assumed coverage on shares of Trupanion in a report on Friday, July 19th. They set an “outperform” rating for the company. Stifel Nicolaus lifted their price objective on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Finally, Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Four analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $41.83.

Trupanion Stock Performance

Shares of TRUP opened at $41.19 on Wednesday. The company’s 50 day simple moving average is $41.73 and its 200-day simple moving average is $32.42. The firm has a market cap of $1.74 billion, a PE ratio of -64.36 and a beta of 1.74. Trupanion has a 12-month low of $19.14 and a 12-month high of $49.14. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The business had revenue of $314.80 million during the quarter, compared to analysts’ expectations of $309.33 million. During the same period in the prior year, the company earned ($0.33) earnings per share. The business’s revenue was up 16.3% compared to the same quarter last year. As a group, equities analysts predict that Trupanion will post -0.34 EPS for the current year.

Insider Buying and Selling

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,764 shares of company stock valued at $405,238. Corporate insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

Several institutional investors and hedge funds have recently made changes to their positions in TRUP. Vanguard Group Inc. increased its holdings in Trupanion by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock valued at $101,433,000 after acquiring an additional 32,485 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Trupanion by 34.6% in the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock valued at $74,862,000 after purchasing an additional 630,155 shares during the last quarter. 8 Knots Management LLC increased its stake in shares of Trupanion by 87.0% during the 1st quarter. 8 Knots Management LLC now owns 1,297,485 shares of the financial services provider’s stock worth $35,824,000 after purchasing an additional 603,775 shares in the last quarter. Marshall Wace LLP raised its position in shares of Trupanion by 11.9% during the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after purchasing an additional 116,496 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new stake in Trupanion during the 2nd quarter valued at $4,739,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.